Serum insulin-like growth factor 1 and late-life depression: A population-based study

Psychoneuroendocrinology

Volumn 54, Issue , 2015, Pages 31-40

  van Varsseveld, N C ^a   van Bunderen, C C ^a   Sohl, E ^a   Comijs, H C ^a   Penninx, B W J H ^a   Lips, P ^a   Drent, M L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Depression; Depressive symptoms; Elderly; Insulin like growth factor 1

Indexed keywords

SOMATOMEDIN C;

AGE DISTRIBUTION; AGED; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIAGNOSTIC INTERVIEW SCHEDULE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LATE LIFE DEPRESSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINOR DEPRESSION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYMPTOM; TREND STUDY; AGE; BLOOD; DEPRESSIVE DISORDER, MAJOR; METABOLISM; NETHERLANDS; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; NETHERLANDS; PROSPECTIVE STUDIES;

EID: 84924457255     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2015.01.014     Document Type: Article

References (44)

1. Adem A., Jossan S.S., d'Argy R., Gillberg P.G., Nordberg A., Winblad B., Sara V. Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization. Brain Res. 1989, 503:299-303.
2. Alexopoulos G.S. Depression in the elderly. Lancet 2005, 365:1961-1970.
3. Arwert L.I., Deijen J.B., Drent M.L. The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Horm. IGF Res. 2005, 15:416-422.
4. Bartke A. Growth hormone and aging: a challenging controversy. Clin. Interv. Aging 2008, 3:659-665.
5. Beekman A.T., Copeland J.R., Prince M.J. Review of community prevalence of depression in later life. Br. J. Psychiatry 1999, 174:307-311.
6. Beekman A.T., Deeg D.J., Van L.J., Braam A.W., De Vries M.Z., van T.W. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol. Med. 1997, 27:231-235.
7. Bremmer M.A., Deeg D.J., Beekman A.T., Penninx B.W., Lips P., Hoogendijk W.J. Major depression in late life is associated with both hypo- and hypercortisolemia. Biol. Psychiatry 2007, 62:479-486.
8. Burman P., Johansson A.G., Siegbahn A., Vessby B., Karlsson F.A. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J. Clin. Endocrinol. Metab. 1997, 82:550-555.
9. Clase C.M., St Pierre M.W., Churchill D.N. Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease. Nephrol. Dial. Transplant. 2001, 16:1925-1929.
10. Copeland J.R., Beekman A.T., Braam A.W., Dewey M.E., Delespaul P., Fuhrer R., Hooijer C., Lawlor B.A., Kivela S.L., Lobo A., Magnusson H., Mann A.H., Meller I., Prince M.J., Reischies F., Roelands M., Skoog I., Turrina C., deVries M.W., Wilson K.C. Depression among older people in Europe: the EURODEP studies. World Psychiatry 2004, 3:45-49.
11. Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocr. Rev. 1993, 14:20-39.
12. Cuijpers P., Vogelzangs N., Twisk J., Kleiboer A., Li J., Penninx B.W. Differential mortality rates in major and subthreshold depression: meta-analysis of studies that measured both. Br. J. Psychiatry 2013, 202:22-27.
13. de Boer H., Blok G.J., van der Veen E.A. Clinical aspects of growth hormone deficiency in adults. Endocr. Rev. 1995, 16:63-86.
14. Deeg D.J., van T.T., Smit J.H., de Leeuw E.D. Attrition in the Longitudinal Aging Study Amsterdam. The effect of differential inclusion in side studies. J. Clin. Epidemiol. 2002, 55:319-328.
15. Deuschle M., Blum W.F., Strasburger C.J., Schweiger U., Weber B., Korner A., Standhardt H., Gotthardt U., Schmider J., Pflaum C.D., Heuser I. Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients. Psychoneuroendocrinology 1997, 22:493-503.
16. Duman C.H., Schlesinger L., Terwilliger R., Russell D.S., Newton S.S., Duman R.S. Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise. Behav. Brain Res. 2009, 198:366-371.
17. Duman R.S. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med. 2004, 5:11-25.
18. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
19. Franz B., Buysse D.J., Cherry C.R., Gray N.S., Grochocinski V.J., Frank E., Kupfer D.J. Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication. J. Psychiatr. Res. 1999, 33:121-127.
20. Garretsen H. Probleemdrinken: prevalentiebepaling, beinvloedende factoren en preventiemogelijkheden. Theoretische overwegingen en onderzoek in Rotterdam. 1983, (Ph.D. dissertation in Dutch), Swets and Zeitlinger, Lisse.
21. Giusti M., Meineri I., Malagamba D., Cuttica C.M., Fattacciu G., Menichini U., Rasore E., Giordano G. Impact of recombinant human growth hormone treatment on psychological profiles in hypopituitary patients with adult-onset growth hormone deficiency. Eur. J. Clin. Invest. 1998, 28:13-19.
22. Katic M., Kahn C.R. The role of insulin and IGF-1 signaling in longevity. Cell. Mol. Life Sci. 2005, 62:320-343.
23. Kokshoorn N.E., Biermasz N.R., Roelfsema F., Smit J.W., Pereira A.M., Romijn J.A. GH replacement therapy in elderly GH-deficient patients: a systematic review. Eur. J. Endocrinol. 2011, 164:657-665.
24. Lesch K.P., Laux G., Erb A., Pfuller H., Beckmann H. Growth hormone (GH) and prolactin responses after GH-releasing hormone in major depressive disorder: relationship to somatomedin C levels and dexamethasone suppressibility of cortisol. Psychoneuroendocrinology 1988, 13:255-263.
25. Lesch K.P., Rupprecht R., Muller U., Pfuller H., Beckmann H. Insulin-like growth factor I in depressed patients and controls. Acta Psychiatr. Scand. 1988, 78:684-688.
26. Mahajan T., Crown A., Checkley S., Farmer A., Lightman S. Atypical depression in growth hormone deficient adults, and the beneficial effects of growth hormone treatment on depression and quality of life. Eur. J. Endocrinol. 2004, 151:325-332.
27. Mendlewicz J., Linkowski P., Kerkhofs M., Desmedt D., Golstein J., Copinschi G., Van C.E. Diurnal hypersecretion of growth hormone in depression. J. Clin. Endocrinol. Metab. 1985, 60:505-512.
28. Mitschelen M., Yan H., Farley J.A., Warrington J.P., Han S., Herenu C.B., Csiszar A., Ungvari Z., Bailey-Downs L.C., Bass C.E., Sonntag W.E. Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: a potential model of geriatric depression. Neuroscience 2011, 185:50-60.
29. Munzer T., Harman S.M., Sorkin J.D., Blackman M.R. Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men. J. Clin. Endocrinol. Metab. 2009, 94:3833-3841.
30. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1:385-401.
31. Robins L.N., Helzer J.E., Croughan J., Ratcliff K.S. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch. Gen. Psychiatry 1981, 38:381-389.
32. Rupprecht R., Rupprecht C., Rupprecht M., Noder M., Lesch K.P., Mossner J. Effects of glucocorticoids on the regulation of the hypothalamic-pituitary-somatotropic system in depression. J. Affect. Disord. 1989, 17:9-16.
33. Scafato E., Galluzzo L., Ghirini S., Gandin C., Rossi A., Solfrizzi V., Panza F., Di C.A., Maggi S., Farchi G. Changes in severity of depressive symptoms and mortality: the Italian Longitudinal Study on Aging. Psychol. Med. 2012, 42:2619-2629.
34. Schilling C., Blum W.F., Heuser I., Paslakis G., Wudy S.A., Deuschle M. Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid. J. Clin. Psychopharmacol. 2011, 31:390-392.
35. Schneider H.J., Pagotto U., Stalla G.K. Central effects of the somatotropic system. Eur. J. Endocrinol. 2003, 149:377-392.
36. Sievers C., Auer M.K., Klotsche J., Athanasoulia A.P., Schneider H.J., Nauck M., Volzke H., John U., Schulz A., Freyberger H.J., Friedrich N., Biffar R., Stalla G.K., Wallaschofski H., Grabe H.J. IGF-I levels and depressive disorders: results from the Study of Health in Pomerania (SHIP). Eur. Neuropsychopharmacol. 2014, 24:890-896.
37. Sievers C., Dimopoulou C., Pfister H., Lieb R., Steffin B., Roemmler J., Schopohl J., Mueller M., Schneider H.J., Ising M., Wittchen H.U., Stalla G.K. Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clin. Endocrinol. (Oxf.) 2009, 71:691-701.
38. Stel V.S., Smit J.H., Pluijm S.M., Visser M., Deeg D.J., Lips P. Comparison of the LASA Physical Activity Questionnaire with a 7-day diary and pedometer. J. Clin. Epidemiol. 2004, 57:252-258.
39. van Bunderen C.C., Oosterwerff M.M., van Schoor N.M., Deeg D.J., Lips P., Drent M.L. Serum IGF1, metabolic syndrome, and incident cardiovascular disease in older people: a population-based study. Eur. J. Endocrinol. 2013, 168:393-401.
40. van Bunderen C.C., van N.I., van Schoor N.M., Deeg D.J., Lips P., Drent M.L. The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study. J. Clin. Endocrinol. Metab. 2010, 95:4616-4624.
41. Voderholzer U., Laakmann G., Wittmann R., Daffner-Bujia C., Hinz A., Haag C., Baghai T. Profiles of spontaneous 24-hour and stimulated growth hormone secretion in male patients with endogenous depression. Psychiatry Res. 1993, 47:215-227.
42. Weber-Hamann B., Blum W.F., Kratzsch J., Gilles M., Heuser I., Deuschle M. Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment. Pharmacopsychiatry 2009, 42:23-28.
43. White I.R., Royston P., Wood A.M. Multiple imputation using chained equations: issues and guidance for practice. Stat. Med. 2011, 30:377-399.
44. Yeap B.B., Paul Chubb S.A., Lopez D., Ho K.K., Hankey G.J., Flicker L. Associations of insulin-like growth factor-I and its binding proteins and testosterone with frailty in older men. Clin. Endocrinol. (Oxf.) 2013, 78:752-759.